Sunho Biologics, Inc. (HKG:2898)

Sunho Biologics Statistics

Total Valuation

Sunho Biologics has a market cap or net worth of HKD 970.43 million. The enterprise value is 596.44 million.

Market Cap	970.43M
Enterprise Value	596.44M

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

Sunho Biologics has 151.87 million shares outstanding. The number of shares has increased by 51.27% in one year.

Current Share Class	151.87M
Shares Outstanding	151.87M
Shares Change (YoY)	+51.27%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	57.95%
Owned by Institutions (%)	n/a
Float	34.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	52,095.17
PB Ratio	1.84
P/TBV Ratio	1.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.63
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.25

Financial Position

The company has a current ratio of 6.59, with a Debt / Equity ratio of 0.14.

Current Ratio	6.59
Quick Ratio	5.64
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-1.03
Interest Coverage	-76.20

Financial Efficiency

Return on equity (ROE) is -15.95% and return on invested capital (ROIC) is -9.96%.

Return on Equity (ROE)	-15.95%
Return on Assets (ROA)	-9.81%
Return on Invested Capital (ROIC)	-9.96%
Return on Capital Employed (ROCE)	-18.57%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	146
Profits Per Employee	-702,729
Employee Count	128
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+60.15%
50-Day Moving Average	6.72
200-Day Moving Average	6.65
Relative Strength Index (RSI)	42.70
Average Volume (20 Days)	3,960

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sunho Biologics had revenue of HKD 18,628 and -89.95 million in losses. Loss per share was -0.60.

Revenue	18,628
Gross Profit	18,628
Operating Income	-98.45M
Pretax Income	-89.95M
Net Income	-89.95M
EBITDA	-90.69M
EBIT	-98.45M
Loss Per Share	-0.60

Balance Sheet

The company has 448.77 million in cash and 74.78 million in debt, with a net cash position of 373.99 million or 2.46 per share.

Cash & Cash Equivalents	448.77M
Total Debt	74.78M
Net Cash	373.99M
Net Cash Per Share	2.46
Equity (Book Value)	527.36M
Book Value Per Share	3.47
Working Capital	453.64M

Cash Flow

In the last 12 months, operating cash flow was -27.33 million and capital expenditures -44.98 million, giving a free cash flow of -72.30 million.

Operating Cash Flow	-27.33M
Capital Expenditures	-44.98M
Free Cash Flow	-72.30M
FCF Per Share	-0.48

Margins

Gross Margin	100.00%
Operating Margin	-528,495.69%
Pretax Margin	-482,871.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Sunho Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.27%
Shareholder Yield	-51.27%
Earnings Yield	-9.27%
FCF Yield	-7.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sunho Biologics has an Altman Z-Score of 4.74 and a Piotroski F-Score of 1.

Altman Z-Score	4.74
Piotroski F-Score	1